These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 9077483

  • 1. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo.
    Kang S, Li XY, Duell EA, Voorhees JJ.
    J Invest Dermatol; 1997 Apr; 108(4):513-8. PubMed ID: 9077483
    [Abstract] [Full Text] [Related]

  • 2. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK.
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid.
    Kane KF, Langman MJ, Williams GR.
    Cancer Res; 1996 Feb 01; 56(3):623-32. PubMed ID: 8564982
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.
    MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC, Haussler CA, Ozato K, Haussler MR.
    Mol Cell Biol; 1993 Sep 01; 13(9):5907-17. PubMed ID: 8395017
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.
    Li XY, Xiao JH, Feng X, Qin L, Voorhees JJ.
    J Invest Dermatol; 1997 Apr 01; 108(4):506-12. PubMed ID: 9077482
    [Abstract] [Full Text] [Related]

  • 8. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
    Sørensen S, Sølvsten H, Politi Y, Kragballe K.
    Skin Pharmacol; 1997 Apr 01; 10(3):144-52. PubMed ID: 9287395
    [Abstract] [Full Text] [Related]

  • 9. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M, Freedman LP, Li H, Christakos S.
    Mol Endocrinol; 1998 Sep 01; 12(9):1367-79. PubMed ID: 9731705
    [Abstract] [Full Text] [Related]

  • 10. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S, Shevde NK, Pike JW.
    J Bone Miner Res; 2005 Feb 01; 20(2):305-17. PubMed ID: 15647825
    [Abstract] [Full Text] [Related]

  • 11. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, Vandewalle M, Carlberg C, Bouillon R.
    J Bone Miner Res; 2001 Apr 01; 16(4):625-38. PubMed ID: 11315990
    [Abstract] [Full Text] [Related]

  • 12. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y, Pike JW, Koeffler HP.
    Leuk Res; 1995 Mar 01; 19(3):147-58. PubMed ID: 7700077
    [Abstract] [Full Text] [Related]

  • 13. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
    Sneddon WB, Barry EL, Coutermarsh BA, Gesek FA, Liu F, Friedman PA.
    Cell Physiol Biochem; 1998 Mar 01; 8(5):261-77. PubMed ID: 9792954
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 1,25-Dihydroxyvitamin D(3) and 9-cis-retinoids are synergistic regulators of 24-hydroxylase activity in the rat and 1, 25-dihydroxyvitamin D(3) alters retinoic acid metabolism in vivo.
    Reinhardt TA, Koszewski NJ, Omdahl J, Horst RL.
    Arch Biochem Biophys; 1999 Aug 15; 368(2):244-8. PubMed ID: 10441374
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
    Jensen TJ, Henriksen LO, Sølvsten H, Kragballe K.
    Biochem Pharmacol; 1998 Mar 15; 55(6):767-73. PubMed ID: 9586948
    [Abstract] [Full Text] [Related]

  • 19. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
    Muto A, Kizaki M, Yamato K, Kawai Y, Kamata-Matsushita M, Ueno H, Ohguchi M, Nishihara T, Koeffler HP, Ikeda Y.
    Blood; 1999 Apr 01; 93(7):2225-33. PubMed ID: 10090931
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.